Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $180

Benzinga · 10/14 14:27
Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $170 to $180.